Speaker Profile
Biography
Deepak Voora, MD, is AssociateProfessor of Medicine at the Center for Applied Genomics Precision Medicine at Duke University School of Medicineand a staff cardiologist at theDurham Veterans Affairs Medical Center. His research focusses on the discovery and translation of pharmacogenomic biomarkers to address the hypothesisthat tailoringdrug therapy on the basis of genomic information can improve health outcomes.He has chosen some of the most commonly used medications used worldwide antiplatelet and statin medications for his researchprogram. As Director of the VA Pharmacogenomics testing for Veterans (PHASER)program, he is leading the VAs national implementation of pre-emptive, panel-based, pharmacogenetic testing to up to 250,000 Veterans.
Session Abstract – PMWC 2025 Silicon Valley
Track Chair:
Kristine Ashcraft, YouScript
Program Theme: Addressing Persistent PGx Myths
- PMWC Award Ceremony:
Luminary Honoree: Philip E. Empey, UPMC
Pioneer Honoree: Collen Masimirembwa, University of the Witwatersrand
- Keynote: Genomic Diversity in Africa: Pharmacogenetics and Clinical Applications
- Collen Masimirembwa, University of the Witwatersrand
- PGx is Expensive and Insurance Coverage is Limited (PANEL)
Chair: Jai Patel, Atrium Health
- Lena Chaihorskym, Alva10
- Mark Fleury, ACS CAN
- Kristin Wiisanen, Rosalind Franklin University
- Alison L. Quinn, Kaiser - Science Backing PGx is Limited (PANEL)
Chair: Sara Rogers, American Society of Pharmacovigilance
- Russ Altman, Stanford
- Philip E. Empey, UPMC
- PGx is Hard to Implement (PANEL)
Chair: Kristine Crews, St Jude
- Suzanne Stevens, Wentworth-Douglass Hospital
- Deepak Voora, VA
- Jason Roos, ARPA-H
- Jennifer Wick, The Christ Hospital Health Network
- What will It Take to Make PGx the Standard of Care? (PANEL)
Chair: Kristine Ashcraft, YouScript
- Alan Venook, UCSF/ NCCN
- Gary Marchant, ASU
- Dan Hertz, University of Michigan
- Deepak Voora, VA